# Daily Co-trimoxazole Prophylaxis to Prevent Malaria in Pregnancy

> **NCT00711906** · PHASE3 · TERMINATED · sponsor: **Institute of Tropical Medicine, Belgium** · enrollment: 352 (actual)

## Conditions studied

- Malaria in Pregnancy

## Interventions

- **DRUG:** Cotrimoxazole
- **DRUG:** Sulfadoxine-pyrimethamine

## Key facts

- **NCT ID:** NCT00711906
- **Lead sponsor:** Institute of Tropical Medicine, Belgium
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-02
- **Primary completion:** 2010-02
- **Final completion:** 2010-09
- **Target enrollment:** 352 (ACTUAL)
- **Why stopped:** Malaria prev. fell in the study area, so we cannot evaluate the primary endpoint
- **Last updated:** 2016-01-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00711906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00711906, "Daily Co-trimoxazole Prophylaxis to Prevent Malaria in Pregnancy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00711906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*